NSE ScannerComparison · NSE · data 2026-11-01
OneSource Specialty Pharma Limited vs Shilpa Medicare Limited
In plain words
Size: Shilpa Medicare Limited is about 1 times the market value of OneSource Specialty Pharma Limited.
Return on equity: Shilpa Medicare Limited 9.8% vs OneSource Specialty Pharma Limited -1.3%.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ONESOURCE | SHILPAMED | |
|---|---|---|
| Price | ₹1,563 | ₹955.6 |
| Market cap | ₹17,926 cr | ₹18,671 cr |
| P/E | — | 62.9 |
| P/B | 3 | — |
| ROE | -1.3% | 9.8% |
| ROCE | -0.1% | 9.0% |
| Debt / equity | 0.26 | 0.25 |
| Operating margin | 6.4% | 21.0% |
| Dividend yield | 0.00% | 0.06% |
| Sales growth, 3 years (yearly) | 232.4% | 13.8% |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | -15.1% | 166.2% |
| Revenue, last 12 months | ₹1,684 cr | ₹1,682 cr |
| Net profit, last 12 months | ₹-2 cr | ₹297 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹25 cr | ₹101 cr |
| Quarter profit vs a year earlier | — | +115.1% |
| Promoter holding | 30.47% | 40.13% |
| Health check | Weak (3.5/10) | Average (6.3/10) |
Common questions
Which earns a higher return on equity?
Shilpa Medicare Limited (9.8% against -1.3%).
Which carries more debt?
OneSource Specialty Pharma Limited has the higher debt-to-equity ratio (0.26 against 0.25).